PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F08U9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $190,453
Award facts
- Contract value 100% obligated
- $190,453.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $190,453.40, was awarded on January 19, 2026, to AmerisourceBergen Drug Corp (Cage 0U9U0), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply delivery to support federal medical procurement needs. The contract is non-competitive with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 20, 2026. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the Defense Logistics Agency Troop Support Medical's Pharmaceutical Prime Vendor Global Program, an Indefinite Delivery Contract valued at up to $999.99 million through December 2026, which enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare systems worldwide.
The funding agency for this award is the Department of Defense's Medical Supply Chain division. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in fulfilling defense medical procurement requirements through competitive awards, with delivery orders typically involving brand-name and generic medications, specialty pharmaceuticals for diabetes and neurological conditions, pain management products, antibiotics, and medical devices. The parent company, Cencora, Inc., also maintains a larger Indefinite Delivery Contract with the Defense Logistics Agency valued at up to $999.99 million through December 31, 2031, positioning the organization as a critical vendor for military treatment facilities and government healthcare systems globally.
Quick answers
Who was awarded contract SPE2D826F08U9?
SPE2D826F08U9 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826F08U9 worth?
The government has obligated $190,453 on SPE2D826F08U9.
Is contract SPE2D826F08U9 an order under another contract?
Yes. SPE2D826F08U9 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D826F08U9 competed?
The extent of competition for SPE2D826F08U9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award